BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35955552)

  • 1. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA.
    Chen IT; Cheng AC; Liu YT; Yan C; Cheng YC; Chang CF; Tseng PH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
    Wang L; Zhu R; Huang Z; Li H; Zhu H
    Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma.
    Wang T; Fu X; Jin T; Zhang L; Liu B; Wu Y; Xu F; Wang X; Ye K; Zhang W; Ye L
    EBioMedicine; 2019 Jul; 45():168-180. PubMed ID: 31278071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma.
    Ji J; Zhao L; Budhu A; Forgues M; Jia HL; Qin LX; Ye QH; Yu J; Shi X; Tang ZY; Wang XW
    J Hepatol; 2010 May; 52(5):690-7. PubMed ID: 20338660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of miR-122 to the innate immunity by regulating toll-like receptor 4 in hepatoma cells.
    Shi L; Zheng X; Fan Y; Yang X; Li A; Qian J
    BMC Gastroenterol; 2019 Jul; 19(1):130. PubMed ID: 31340754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
    Ding H; Zhang X; Su Y; Jia C; Dai C
    Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A).
    Lan FF; Wang H; Chen YC; Chan CY; Ng SS; Li K; Xie D; He ML; Lin MC; Kung HF
    Int J Cancer; 2011 Jan; 128(2):319-31. PubMed ID: 20309945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
    Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
    Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
    Lin FY; Chen YH; Lin YW; Tsai JS; Chen JW; Wang HJ; Chen YL; Li CY; Lin SJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2622-9. PubMed ID: 16990552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2.
    Feng W; Chen J; Huang W; Wang G; Chen X; Duan L; Yin Y; Chen X; Zhang B; Sun M; Luo X; Nie Y; Fan D; Wu K; Xia L
    Theranostics; 2023; 13(12):4042-4058. PubMed ID: 37554278
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of down-regulation of let-7c/g on triggering a double-negative feedback loop and promoting restenosis.
    Zhang Q; Zhou X; Li X; Yao S; Jiang S; Zhang R; Zou Z; Liao L; Dong J
    Chin Med J (Engl); 2023 Oct; 136(20):2484-2495. PubMed ID: 37433785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
    Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
    Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reexpression of Let-7g microRNA inhibits the proliferation and migration via K-Ras/HMGA2/snail axis in hepatocellular carcinoma.
    Chen KJ; Hou Y; Wang K; Li J; Xia Y; Yang XY; Lv G; Xing XL; Shen F
    Biomed Res Int; 2014; 2014():742417. PubMed ID: 24724096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.
    Zhou S; Du R; Wang Z; Shen W; Gao R; Jiang S; Fang Y; Shi Y; Chang A; Liu L; Liu C; Li N; Xiang R
    Cancer Med; 2019 May; 8(5):2325-2337. PubMed ID: 30957973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11.
    Gaza A; Fritz V; Malek L; Wormser L; Treiber N; Danner J; Kremer AE; Thasler WE; Siebler J; Meister G; Neurath MF; Hellerbrand C; Bosserhoff AK; Dietrich P
    Neoplasia; 2021 May; 23(5):502-514. PubMed ID: 33901943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.
    Wei X; Liu H; Li X; Liu X
    Ann Hepatol; 2019; 18(6):869-878. PubMed ID: 31477445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
    Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma.
    Xu WP; Yi M; Li QQ; Zhou WP; Cong WM; Yang Y; Ning BF; Yin C; Huang ZW; Wang J; Qian H; Jiang CF; Chen YX; Xia CY; Wang HY; Zhang X; Xie WF
    Hepatology; 2013 Dec; 58(6):1977-91. PubMed ID: 23728999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4.
    Lin Y; Yu LX; Yan HX; Yang W; Tang L; Zhang HL; Liu Q; Zou SS; He YQ; Wang C; Wu MC; Wang HY
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1090-102. PubMed ID: 22617167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.